Fullcircle Wealth »

Summit Therapeutics shares owned by Fullcircle Wealth

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Fullcircle Wealth from 13F filings

Historical chart of Fullcircle Wealth investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Fullcircle Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Fullcircle Wealth

Quarter filed Position value Share count Share price at filing
2024-06-30 $122k 12k 9.98

More positions owned by Fullcircle Wealth

United Parcel Service CL B (UPS)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Snowflake Cl A (SNOW)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Ibonds 24 Trm Ts (IBTE)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Ser Tr Bloomberg High Y (JNK)
Texas Instruments Incorporated (TXN)
Unilever Spon Adr New (UL)
Ishares Tr Core Total Usd (IUSB)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)

View all positions for Fullcircle Wealth

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Millennium Management
Caption Management
Balyasny Asset Management
Frigate Ventures
Charles Schwab Investment Management
Susquehanna International
QVT Financial
Federated Investors
Goldman Sachs Group

View all funds holding Summit Therapeutics